STOCK TITAN
  1. Home
  2. Sec-filings
  3. JAGX
  4. [EFFECT] Jaguar Health, Inc. SEC Filing

[EFFECT] Jaguar Health, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 27, 2025 4:00 P.M.
Form: S-3
CIK: 0001585608
Company Name: Jaguar Health, Inc.
File Number: 333-288202

Source: View Original Filing on SEC EDGAR

Stock JAGX logo
Jaguar Health Inc

NASDAQ:JAGX

JAGX Rankings

#6490 Ranked by Market Cap
N/A Ranked by Dividends

JAGX Latest News

Sep 30, 2025
FDA-Authorized Expanded Access Programs Utilizing Jaguar Health's Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease
Sep 25, 2025
Jaguar Health Receives Notice of $250,000 FDA Grant to Fund Confirmatory Trial to Support FDA Approval of Canalevia for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Sep 24, 2025
Jaguar Health Submits Orphan Drug Designation Application to FDA for Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Patients with Breast Cancer with Metastasis Identified by FDA as a Distinct Condition
Sep 23, 2025
Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts
Sep 5, 2025
Jaguar Health Presenting at September 8-10 H.C. Wainwright Annual Global Investment Conference to Provide Updates on Near-Term Catalysts

JAGX Latest SEC Filings

Oct 3, 2025
[8-K] Jaguar Health, Inc. Reports Material Event
Oct 3, 2025
[S-3] Jaguar Health, Inc. Shelf Registration Statement
Oct 1, 2025
[8-K] Jaguar Health, Inc. Reports Material Event
Sep 23, 2025
[D] Jaguar Health, Inc. SEC Filing
Sep 23, 2025
[D] Jaguar Health, Inc. SEC Filing

JAGX Stock Data

4.81M
2.53M
34.76%
0.63%
3.04%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN FRANCISCO